110 related articles for article (PubMed ID: 4781516)
1. The cervical relaxant properties of prostaglandin E2 in non pregnant subjects.
Ostergard DR
Prostaglandins; 1973 Nov; 4(5):701-2. PubMed ID: 4781516
[TBL] [Abstract][Full Text] [Related]
2. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
Brenner WE; Dingfelder JR; Staurovsky LG; Hendricks CH
Prostaglandins; 1973 Dec; 4(6):819-36. PubMed ID: 4783581
[TBL] [Abstract][Full Text] [Related]
3. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
4. Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2 alpha methyl ester.
Frankman O; Bygdeman M; Gréen K; Moberg P; Sandberg CG
Contraception; 1980 Jun; 21(6):571-6. PubMed ID: 7428365
[TBL] [Abstract][Full Text] [Related]
5. Low-dose vaginal 15 methyl prostaglandin F2 alpha for cervical dilatation prior to vacuum curettage abortion.
Niloff JM; Stubblefield PG
Am J Obstet Gynecol; 1982 Mar; 142(5):596-7. PubMed ID: 7036748
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
Hald F; Kristoffersen SE; Gregersen E
Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
[TBL] [Abstract][Full Text] [Related]
8. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
9. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
10. A new iud insertion technique utilizing cervical priming with prostaglandin.
Lauersen NH; Kurkulos M; Graves ZR; Leeds L
Contraception; 1982 Jul; 26(1):59-63. PubMed ID: 7128135
[TBL] [Abstract][Full Text] [Related]
11. Internal and external cervical os dilation with vaginal 15-methyl prostaglandin F2 alpha.
Fayemi A; Schulman H; Mitchell J; Fleischer A
Am J Obstet Gynecol; 1983 May; 146(2):219-20. PubMed ID: 6846441
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 induction of abortion and fetal demise.
Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysis.
Rayburn WF
Am J Obstet Gynecol; 1989 Mar; 160(3):529-34. PubMed ID: 2648830
[TBL] [Abstract][Full Text] [Related]
15. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
Ganguli AC; Gréen K; Bygdeman M
Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
[TBL] [Abstract][Full Text] [Related]
17. The use of prostaglandin pessaries prior to vaginal termination.
Craft I
Prostaglandins; 1973 Mar; 3(3):377-81. PubMed ID: 4729580
[TBL] [Abstract][Full Text] [Related]
18. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
Somell C; Olund A; Kindahl H; Larsson B
Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
[TBL] [Abstract][Full Text] [Related]
19. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
20. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
